Lymphatic channel density in colorectal adenocarcinoma
نویسندگان
چکیده
منابع مشابه
Mucinous and Non-Mucinous Adenocarcinoma in Colorectal Cancer Patients
Background: The oncologic behavior of mucinous adenocarcinoma (MA) of colorectal differs from non-mucinous adenocarcinoma (NMA). MA is more advanced at diagnosis and has a poorer prognosis than NMA. We aimed to evaluate prognostic factors and survival rate in patients with MA compared with NMA in Western Iran. Methods: During 2008-2015 in a retrospective study, 83 patients with CRC referred to...
متن کاملA case report of invasive ductal adenocarcinoma identified in a lymphatic channel: a staging controversy.
A 65-year-old woman underwent core biopsy of a palpable left breast mass. This was a Nottingham grade II invasive ductal carcinoma with lymphovascular invasion. The tumor was ER/PR positive and Her-2/neu negative. The patient agreed to participate in the American College of Surgeon’s Oncology Group Z00100 trial. Two weeks later, the patient underwent a left breast lumpectomy, sentinel lymph nod...
متن کاملLymphatic vessel density and its prognostic value in stage I colorectal carcinoma.
AIMS The assessment of lymphatic vessel density (LVD) has been suggested as a tool to determine the metastatic risk of neoplasias. On this premise, the authors aimed to verify whether progression risk of stage I colorectal cancer may be related to LVD. The authors also evaluated and correlated vascular endothelial growth factor (VEGF)-A expression with LVD revealed in the same cases in order to...
متن کاملFGFR2 amplification in colorectal adenocarcinoma
FGFR2 is recurrently amplified in 5% of gastric cancers and 1%-4% of breast cancers; however, this molecular alteration has never been reported in a primary colorectal cancer specimen. Preclinical studies indicate that several FGFR tyrosine-kinase inhibitors (TKIs), such as AZD4547, have in vitro activity against the FGFR2-amplified colorectal cell line, NCI-H716. The efficacy of these inhibito...
متن کاملAnalysis of TP53 Codon 72 Polymorphism in Mucinous and Non-Mucinous Colorectal Adenocarcinoma in Isfahan, Iran
Background: The tumor suppressor gene TP53 (alias p53) located on chromosome 17 is involved in various cancers. Case-control studies have shown that p53 codon 72 polymorphism modulates the prognosis and susceptibility to various malignancies. We undertook the present study to explore a possible association between mucinous and non-mucinous adenocarcinomas with different genotypes or alleles at ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Pathology and Microbiology
سال: 2010
ISSN: 0377-4929
DOI: 10.4103/0377-4929.59175